Planning

Vendor Managed Inventory Service

CELL THERAPY CATAPULT LIMITED

This public procurement record has 1 release in its history.

Planning

18 Nov 2016 at 20:17

Market Engagement Notice
Summary of the contracting process

The Cell Therapy Catapult Limited is currently in the planning stage of a procurement process for a Vendor Managed Inventory Service. This initiative is aimed at supporting the new £55 million advanced therapy medicinal product manufacturing centre in Stevenage, Hertfordshire, which is set to open in May 2017. The engagement end date for market feedback is 23rd February 2018. This project falls under the building and facilities management services category, specifically within inventory management processes for the provision of clinical materials and regulatory compliance.

This tender presents a significant opportunity for businesses in supply chain management, warehouse logistics, and regulatory compliance sectors. Companies with expertise in inventory management software, as well as those specialising in on-site warehousing and materials management, would be particularly well-suited to compete for this contract. Engaging with the Cell Therapy Catapult Limited could lead to further collaborations and growth, especially considering the innovative nature of the advanced therapies being developed within the UK.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Vendor Managed Inventory Service

Notice Description

Cell & Gene Therapy Catapult (CGTC) is part of a world leading network of technology and innovation centres looking at bridging the gap between businesses, academia, research and government. The long term Government investment being made, is to transform the UK's ability to create new products and services within the cell and Gene Therapy arena, opening up global opportunities for the UK and generate sustained economic growth for the future. The current facilities based on the 12th Floor of Guys St Thomas Hospital in London hosts around 110 personnel, with laboratories covering a square metre space 1,200m. Cell & Gene Therapy Catapult (CGT) is currently building a PS55M large scale advanced therapy medicinal product (ATMP) manufacturing centre (CGTMC) at Stevenage Biocatalyst in Hertfordshire. The CGTMC is planned to open in May 2017 and will be operated as a multi-occupier facility for UK and global companies that are looking to scale-up the manufacture ATMPs for Phase III studies. CGT are currently investigating the possibility of implementing a Vendor Managed Inventory (VMI) service for this manufacturing centre. The service provider would manage the CGTMC supply chain, on and off site warehousing & all processes associated with the management of in process materials, patient/clinical material & final product ensuring regulatory compliance at all times. Cell & Gene Therapy Catapult would like to engage the supply market at this early stage to understand and interpret market intelligence into our decision making process. As such, this PIN does not formally signify the beginning of any procurement and does not constitute a commitment by CGT to undertake any procurement exercise. Your comments are invited on all questions raised in the attached document. Additional information: Your comments are invited on all questions raised within the attached document. Please send completed response documents and any communication via email to: will.baxter@ct.catapult.org.uk. The deadline for submitting completed responses is 3pm, Friday 17th June 2016.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-bf0f7037-adc9-11e6-9901-0019b9f3037b
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/3ea27811-1c90-4a43-8ef1-f76265e5bb36
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Market Engagement Notice
Procurement Type
Standard
Procurement Category
Not specified
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

48 - Software package and information systems

79 - Business services: law, marketing, consulting, recruitment, printing and security

CPV Codes

48430000 - Inventory management software package

79993000 - Building and facilities management services

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
18 Nov 20169 years ago
Submission Deadline
Not specified
Future Notice Date
23 Feb 2018Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planning
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
CELL THERAPY CATAPULT LIMITED
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 9RT
Post Town
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI44 Lewisham and Southwark
Delivery Location
Not specified
Local Authority
Southwark
Electoral Ward
London Bridge & West Bermondsey
Westminster Constituency
Bermondsey and Old Southwark

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-bf0f7037-adc9-11e6-9901-0019b9f3037b-2016-11-18T20:17:31Z",
    "date": "2016-11-18T20:17:31Z",
    "ocid": "ocds-b5fd17-bf0f7037-adc9-11e6-9901-0019b9f3037b",
    "language": "en",
    "initiationType": "tender",
    "title": "Vendor Managed Inventory Service",
    "planning": {
        "milestones": [
            {
                "id": "1",
                "title": "Engagement end date",
                "type": "engagement",
                "dueDate": "2018-02-23T23:59:59Z"
            }
        ],
        "documents": [
            {
                "id": "1",
                "documentType": "marketEngagementNotice",
                "description": "Early engagement notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/3ea27811-1c90-4a43-8ef1-f76265e5bb36",
                "datePublished": "2016-06-06T14:22:14+01:00",
                "format": "text/html",
                "language": "en"
            },
            {
                "id": "2",
                "documentType": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
                "description": "VMI PIN Questions",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/Attachment/cc7796d6-40da-42d0-a159-e595c92345b2",
                "format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document"
            }
        ]
    },
    "tender": {
        "id": "CON-0081",
        "title": "Vendor Managed Inventory Service",
        "description": "Cell & Gene Therapy Catapult (CGTC) is part of a world leading network of technology and innovation centres looking at bridging the gap between businesses, academia, research and government. The long term Government investment being made, is to transform the UK's ability to create new products and services within the cell and Gene Therapy arena, opening up global opportunities for the UK and generate sustained economic growth for the future. The current facilities based on the 12th Floor of Guys St Thomas Hospital in London hosts around 110 personnel, with laboratories covering a square metre space 1,200m. Cell & Gene Therapy Catapult (CGT) is currently building a PS55M large scale advanced therapy medicinal product (ATMP) manufacturing centre (CGTMC) at Stevenage Biocatalyst in Hertfordshire. The CGTMC is planned to open in May 2017 and will be operated as a multi-occupier facility for UK and global companies that are looking to scale-up the manufacture ATMPs for Phase III studies. CGT are currently investigating the possibility of implementing a Vendor Managed Inventory (VMI) service for this manufacturing centre. The service provider would manage the CGTMC supply chain, on and off site warehousing & all processes associated with the management of in process materials, patient/clinical material & final product ensuring regulatory compliance at all times. Cell & Gene Therapy Catapult would like to engage the supply market at this early stage to understand and interpret market intelligence into our decision making process. As such, this PIN does not formally signify the beginning of any procurement and does not constitute a commitment by CGT to undertake any procurement exercise. Your comments are invited on all questions raised in the attached document. Additional information: Your comments are invited on all questions raised within the attached document. Please send completed response documents and any communication via email to: will.baxter@ct.catapult.org.uk. The deadline for submitting completed responses is 3pm, Friday 17th June 2016.",
        "status": "planning",
        "classification": {
            "scheme": "CPV",
            "id": "79993000",
            "description": "Building and facilities management services"
        },
        "additionalClassifications": [
            {
                "scheme": "CPV",
                "id": "48430000",
                "description": "Inventory management software package"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "East of England",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "suitability": {
            "sme": false,
            "vcse": false
        }
    },
    "parties": [
        {
            "id": "GB-SRS-sid4gov.cabinetoffice.gov.uk/zV3N2974",
            "name": "CELL THERAPY CATAPULT LIMITED",
            "identifier": {
                "legalName": "CELL THERAPY CATAPULT LIMITED",
                "scheme": "GB-SRS",
                "id": "sid4gov.cabinetoffice.gov.uk/zV3N2974"
            },
            "address": {
                "streetAddress": "12th Floor Tower Wing, Guys Hospital, Great Maze Pond",
                "locality": "London",
                "postalCode": "SE1 9RT",
                "countryName": "England"
            },
            "contactPoint": {
                "name": "Will Baxter",
                "email": "will.baxter@ct.catapult.org.uk"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-SRS-sid4gov.cabinetoffice.gov.uk/zV3N2974",
        "name": "CELL THERAPY CATAPULT LIMITED"
    }
}